Estimating individualized treatment effects using individual participant data meta-analysis - Archive ouverte HAL Access content directly
Preprints, Working Papers, ... Year : 2022

Estimating individualized treatment effects using individual participant data meta-analysis

Abstract

Different approaches can be used to estimate individualized treatment effects with Individual Participant Data Meta-Analyses (IPD-MA). We compared four one-stage models: random effects (RE), stratified intercept (SI), rank-1 (R1) and fully stratified (FS) models, built with two different strategies constructed with a Monte Carlo simulation study in which we explored different scenarios with a binary or a time-to-event outcome. To evaluate the performance of the models, we used the c-statistic for benefit, the calibration of predictions and the mean squared error. The different models were also used on the INDANA IPD-MA, comparing an anti-hypertensive treatment to no treatment or placebo (N = 40 237, 836 events). Simulation results showed that the random effects and the stratified intercept models performed well for both binary and time-to-event outcomes. For the INDANA dataset with a binary outcome, the random effects model had the best performance.
Fichier principal
Vignette du fichier
PaperITE_V8_neutral.pdf (501.2 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03735613 , version 1 (21-07-2022)

Identifiers

  • HAL Id : hal-03735613 , version 1

Cite

Florie Brion Bouvier, Anna Chaimani, François Gueyffier, Guillaume Grenet, Raphaël Porcher. Estimating individualized treatment effects using individual participant data meta-analysis. 2022. ⟨hal-03735613⟩
155 View
71 Download

Share

Gmail Facebook X LinkedIn More